Daiichi and Cyntellect Partner for Drug Discovery

Under the collaboration, Daiichi will utilize Cyntellect's high-throughput cell imaging and laser-based cell manipulation technology, LEAP, for novel drug discovery. Cyntellect will design, configure and run LEAP cell-based assays against a compound collection provided by Daiichi.

Pharmaceutical Business Review (http://www.pharmaceutical-business-review.com/article_news.asp?guid=F13EFE35-04AE-4E6C-A12C-B9126F073139)